OPEN Health Appoints Zack Lentz as Chief Commercial Officer

OPEN Health, a leader in medical affairs and health economics, announced the appointment of Zack Lentz as its new Chief Commercial Officer on August 27, 2025. With over two decades of experience in the life sciences sector, Lentz will drive growth and enhance client partnerships for the company, ensuring clients leverage the full spectrum of OPEN Health’s integrated capabilities.

In his new role, Lentz will focus on accelerating the company’s growth trajectory and fostering deeper relationships with clients. His extensive background includes senior leadership positions, notably as Chief Growth Officer at Inizio Medical and President & Chief Strategy Officer at Vaniam Group. His career has witnessed the transformation of the pharmaceutical and biotech industries, evolving from the blockbuster era to a more patient-centered approach that emphasizes the connection between science, evidence, access, and patient engagement.

Lentz’s appointment comes at a time when the industry is increasingly seeking innovative solutions to meet patient needs. His philosophy centers on maximizing the value of innovation throughout the product life cycle, which aligns with OPEN Health’s mission to improve patient outcomes globally.

Matt D’Auria, CEO of OPEN Health, expressed his enthusiasm for Lentz’s leadership, stating, “Zack’s proven track record of growth leadership and his deep understanding of the life sciences landscape make him an exceptional addition to OPEN Health.” D’Auria emphasized that Lentz’s strategic vision combined with his focus on team development will strengthen the company’s ability to deliver significant impacts for clients and the patients they serve.

Reflecting on his new role, Lentz shared his excitement, saying, “I am thrilled to join OPEN Health at such a pivotal time for the industry. The company’s commitment to connecting science, evidence, access, and engagement aligns perfectly with my passion for helping clients realize the full potential of their innovations to improve patients’ lives.”

OPEN Health is dedicated to merging scientific expertise with advanced technology to create impactful solutions in the biopharma sector. The organization aims to facilitate faster and smarter routes to market through its comprehensive services in medical affairs and market access.

The appointment of Zack Lentz marks a significant step for OPEN Health as it continues to navigate the complexities of the healthcare landscape, striving to unlock new opportunities for innovation and enhance the overall patient experience.